Estrogen Treatment in Acromegalic Women
Recruitment status was Recruiting
Oral estrogens may be an effective adjuvant treatment for control of acromegaly in patients with resistance to somatostatin analogs.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
|Study Start Date:||May 2006|
|Estimated Study Completion Date:||August 2007|
This will be a canadian multicenter study with a randomized, double-blind, placebo-controlled design, to assess the efficacy and safety of adjuvant alesse in female acromegalic patients with suboptimal response to sandostatin LAR treatment.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00315107
|Contact: Omar SERRI, MD||514-890-8000 ext email@example.com|
|CHUM - Notre-Dame Hospital||Recruiting|
|Montreal, Quebec, Canada, H2L 4M1|
|Principal Investigator: Omar Serri, MD|
|Principal Investigator:||Omar Serri, MD||CHUM- Endocrinology|